Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
+14.69%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$26.8B
AUM Growth
+$3.21B
(+14%)
Cap. Flow
+$333M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
33.69%
Holding
1,279
New
177
Increased
369
Reduced
457
Closed
160
Top Buys
| 1 |
Target
TGT
|
+$173M |
| 2 |
Starbucks
SBUX
|
+$159M |
| 3 |
Amgen
AMGN
|
+$150M |
| 4 |
Ross Stores
ROST
|
+$133M |
| 5 |
3M
MMM
|
+$121M |
Top Sells
| 1 |
Visa
V
|
+$130M |
| 2 |
Eli Lilly
LLY
|
+$110M |
| 3 |
Cisco
CSCO
|
+$107M |
| 4 |
Adobe
ADBE
|
+$102M |
| 5 |
Newmont
NEM
|
+$101M |
Sector Composition
| 1 | Technology | 34.52% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Financials | 13.05% |
| 4 | Industrials | 10.11% |
| 5 | Communication Services | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Beam Therapeutics
BEAM
$2.08B
| $487K | ﹤0.01% |
17,892
-6,873
| -28% | -$187K |
|
877
Rhythm Pharmaceuticals
RYTM
$6.39B
| $487K | ﹤0.01% |
10,593
-2,828
| -21% | -$130K |
|
878
Check Point Software Technologies
CHKP
$21B
| $486K | ﹤0.01% |
3,180
| – | – |
|
879
Utah Medical Products
UTMD
$200M
| $486K | ﹤0.01% |
5,766
| – | – |
|
880
California Resources
CRC
$4.44B
| $485K | ﹤0.01% |
8,873
-3,400
| -28% | -$186K |
|
881
PBF Energy
PBF
$3.18B
| $483K | ﹤0.01% |
10,980
-49,097
| -82% | -$2.16M |
|
882
Century Casinos
CNTY
$76.3M
| $483K | ﹤0.01% |
98,887
| – | – |
|
883
Futu Holdings
FUTU
$25.9B
| $480K | ﹤0.01% |
8,790
-7,982
| -48% | -$436K |
|
|
BIG
884
DELISTED
Big Lots, Inc.
BIG
| $479K | ﹤0.01% |
+61,430
| New | +$479K |
|
|
EGRX
885
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $477K | ﹤0.01% |
91,262
+36,982
| +68% | +$193K |
|
886
Southern Copper
SCCO
$86.2B
| $477K | ﹤0.01% |
5,822
-37,459
| -87% | -$3.07M |
|
887
Stellar Bancorp
STEL
$1.61B
| $475K | ﹤0.01% |
17,058
+700
| +4% | +$19.5K |
|
888
Northrim BanCorp
NRIM
$504M
| $475K | ﹤0.01% |
8,300
+2,140
| +35% | +$122K |
|
889
Midland States Bancorp
MSBI
$385M
| $470K | ﹤0.01% |
+17,043
| New | +$470K |
|
890
Alector
ALEC
$278M
| $469K | ﹤0.01% |
58,756
-111,442
| -65% | -$889K |
|
891
Kodiak Sciences
KOD
$489M
| $468K | ﹤0.01% |
154,099
| – | – |
|
892
Advantage Solutions
ADV
$619M
| $467K | ﹤0.01% |
128,980
+21,650
| +20% | +$78.4K |
|
893
BancFirst
BANF
$4.45B
| $467K | ﹤0.01% |
+4,796
| New | +$467K |
|
|
CHX
894
DELISTED
ChampionX
CHX
| $466K | ﹤0.01% |
15,958
-21,068
| -57% | -$615K |
|
895
Warrior Met Coal
HCC
$3.04B
| $461K | ﹤0.01% |
7,554
-2,380
| -24% | -$145K |
|
896
InMode
INMD
$937M
| $460K | ﹤0.01% |
20,682
-13,234
| -39% | -$294K |
|
897
Mersana Therapeutics
MRSN
$35.6M
| $458K | ﹤0.01% |
7,899
| – | – |
|
898
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $456K | ﹤0.01% |
136,820
+61,722
| +82% | +$206K |
|
899
Generation Bio
GBIO
$39.9M
| $455K | ﹤0.01% |
27,583
+20,946
| +316% | +$346K |
|
900
Ralph Lauren
RL
$19.1B
| $455K | ﹤0.01% |
+3,155
| New | +$455K |
|